Showing results (211-220 of 297) with videos related to
Sort By:
Pageof 30
The AAPS Journal|March 19, 2020
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer PatientsSpinel Karas, Amy S Etheridge, Eleftheria Tsakalozou, et al.Cancer|October 16, 2004
Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480Tim A Ahles, James E Herndon, Eric J Small, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committeeLesley Seymour, S Percy Ivy, Daniel Sargent, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Two drug interaction studies of sirolimus in combination with sorafenib or sunitinib in patients with advanced malignanciesTara C Gangadhar, Ezra E W Cohen, Kehua Wu, et al.The Oncologist|August 23, 2021
Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology PatientsNatalie Reizine, Keith Danahey, Emily Schierer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2014
Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancerFederico Innocenti, Richard L Schilsky, Jacqueline Ramírez, et al.Clinical Pharmacology and Therapeutics|December 24, 2019
A New Liver Expression Quantitative Trait Locus Map From 1,183 Individuals Provides Evidence for Novel Expression Quantitative Trait Loci of Drug Response, Metabolic, and Sex-Biased PhenotypesAmy S Etheridge, Paul J Gallins, Dereje Jima, et al.American Journal of Respiratory and Critical Care Medicine|September 16, 2014
Genome-wide interrogation of longitudinal FEV1 in children with asthmaKehua Wu, Eric R Gamazon, Hae Kyung Im, et al.Cancer|October 8, 2016
Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)Jonas A de Souza, Bonnie J Yap, Kristen Wroblewski, et al.Pharmacogenetics and Genomics|April 6, 2022
Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertensionVasiliki Thomeas-McEwing, Mitchell A Psotka, Eric R Gamazon, et al.Pageof 30